BSE: SOLARA - Solara Active Pharma Sciences Limited

Yield per half year: -36.88%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Solara Active Pharma Sciences Limited


About Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India.

more details
The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

ISIN INE624Z01016
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.4382
Дивиденд ао 3.04
Сайт https://www.solara.co.in
Цена ао 479.75
Change price per day: 0% (479.75)
Change price per week: -8.39% (523.7)
Change price per month: -4.78% (503.85)
Change price per 3 month: -35.33% (741.85)
Change price per half year: -36.88% (760)
Change price per year: +22.62% (391.25)
Change price per 3 year: -25.35% (642.706)
Change price per 5 year: +14.37% (419.485)
Change price per 10 year: 0% (479.75)
Change price per year to date: -30.16% (686.95)

Underestimation

Title Value Grade
P/S 1.2 9
P/BV 1.59 8
P/E 0 0
EV/EBITDA 14.19 7
Total: 5.25

Efficiency

Title Value Grade
ROA, % -21.63 0
ROE, % -46.55 0
Total: 0.8333

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.6 6
Total: 1.33

Debt

Title Value Grade
Debt/EBITDA 6.39 0
Total: 5.8

Growth impulse

Title Value Grade
Yield Revenue, % -2.31 0
Yield Ebitda, % -43.46 0
Yield EPS, % -468.02 0
Total: 0



Head Job title Payment Year of birth
Mr. Poorvank Purohit MD, CEO & Director N/A 1979 (46 years)
Mr. Mohan Muthunarayanan COO & Executive Director N/A
Mr. Suddapalli Murali Krishna Company Secretary, Compliance Officer & Chief Investor Relations Officer N/A
Mr. Arun Kumar Pillai B.Com. Founder & Non-Executive Director N/A 1961 (64 years)
Mr. V. Sundara Moorthy Chief Quality Officer N/A
Mr. Arun Kumar Baskaran Chief Financial Officer N/A
Dr. Hero Velladurai Chief Scientific Officer N/A

Address: India, Chennai, Admin Block 27 - open in Google maps, open in Yandex maps
Website: https://www.solara.co.in